Analysts: Gentiva Health Services Inc (GTIV.OQ)
GTIV.OQ on NASDAQ Stock Exchange Global Select Market
11.40USD
1 Aug 2013
11.40USD
1 Aug 2013
Price Change (% chg)
$0.66 (+6.15%)
$0.66 (+6.15%)
Prev Close
$10.74
$10.74
Open
$11.28
$11.28
Day's High
$11.82
$11.82
Day's Low
$11.00
$11.00
Volume
127,728
127,728
Avg. Vol
83,561
83,561
52-wk High
$12.89
$12.89
52-wk Low
$6.52
$6.52
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | 0.22 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 1 | 1 | 1 | 1 |
| (3) HOLD | 2 | 2 | 3 | 3 |
| (4) UNDERPERFORM | 2 | 2 | 2 | 2 |
| (5) SELL | 1 | 1 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 3.14 | 3.14 | 2.86 | 2.86 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 7 | 418.79 | 426.07 | 413.20 | 445.37 |
| Quarter Ending Dec-13 | 7 | 425.99 | 432.70 | 418.20 | 453.16 |
| Year Ending Dec-13 | 7 | 1,677.32 | 1,693.56 | 1,660.00 | 1,786.38 |
| Year Ending Dec-14 | 7 | 1,716.13 | 1,753.11 | 1,675.21 | 1,792.60 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 7 | 0.22 | 0.24 | 0.19 | 0.29 |
| Quarter Ending Dec-13 | 7 | 0.25 | 0.29 | 0.20 | 0.34 |
| Year Ending Dec-13 | 7 | 0.92 | 0.98 | 0.82 | 1.19 |
| Year Ending Dec-14 | 7 | 1.04 | 1.32 | 0.78 | 1.09 |
| LT Growth Rate (%) | 2 | 10.00 | 10.00 | 10.00 | 11.00 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 427.95 | 415.59 | 12.36 | 2.89 |
| Quarter Ending Dec-12 | 432.77 | 425.02 | 7.75 | 1.79 |
| Quarter Ending Sep-12 | 428.44 | 424.44 | 4.00 | 0.93 |
| Quarter Ending Jun-12 | 435.26 | 427.69 | 7.57 | 1.74 |
| Quarter Ending Mar-12 | 436.70 | 435.65 | 1.05 | 0.24 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.30 | 0.23 | 0.07 | 22.22 |
| Quarter Ending Dec-12 | 0.34 | 0.32 | 0.02 | 5.88 |
| Quarter Ending Sep-12 | 0.28 | 0.32 | 0.04 | 12.56 |
| Quarter Ending Jun-12 | 0.28 | 0.35 | 0.07 | 26.95 |
| Quarter Ending Mar-12 | 0.28 | 0.27 | 0.01 | 2.07 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 418.79 | 418.79 | 418.79 | 418.79 | 445.37 |
| Quarter Ending Dec-13 | 425.99 | 425.99 | 425.99 | 425.99 | 453.16 |
| Year Ending Dec-13 | 1,677.32 | 1,677.32 | 1,677.32 | 1,677.19 | 1,786.38 |
| Year Ending Dec-14 | 1,716.13 | 1,716.13 | 1,716.13 | 1,717.35 | 1,792.60 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.22 | 0.22 | 0.22 | 0.22 | 0.29 |
| Quarter Ending Dec-13 | 0.25 | 0.25 | 0.25 | 0.26 | 0.34 |
| Quarter Ending Dec-13 | 0.92 | 0.92 | 0.92 | 0.93 | 1.19 |
| Quarter Ending Dec-14 | 1.04 | 1.04 | 1.04 | 1.09 | 1.09 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$127.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates